Wall Street expects a year-over-year decline in earnings on lower revenues when Wave Life Sciences (WVE) reports results for the quarter ended September 2024. While this widely-known consensus outlook ...

Wave Life Sciences (WVE) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.24 per share a year ago. These figures ...

WAVE Life Sciences (WVE) is scheduled to report earnings on March 3, 2026. The last reported earnings were for reported on November 10, 2025 for Q3. The Actual Revenue was $7.6M, which missed the ...

D-Wave Quantum Inc. (QBTS) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.20 per share a year ago. These figures ...

One thing we could say about the analysts on D-Wave Quantum Inc. (NYSE:QBTS) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the ...

The analyst assumed coverage of D-Wave Quantum and says quarterly revenue and adjusted EBITDA are above both the analyst’s and Street estimates, primarily due to stronger system sales. McPeake ...

Bounds on estimates of wave heights (valid for large amplitudes) from pressure and flow measurements at an arbitrary intermediate depth have been provided. Two-dimensional irrotational steady water ...

Wave Life Sciences (WVE) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.25 per share a year ago. These figures ...

Wave Life Sciences (WVE) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.47 per share a year ago. These figures ...